Post-earnings recap
Reported
Thu, Aug 5, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported a loss per share that was slightly worse than expected, but the stock still rose by over 2%. This positive stock reaction may indicate investor optimism despite the earnings miss, possibly due to other underlying factors or market sentiment.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.37 | N/A | -5.71% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.